BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

763 related articles for article (PubMed ID: 10384859)

  • 1. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.
    Lamp KC; Freeman CD; Klutman NE; Lacy MK
    Clin Pharmacokinet; 1999 May; 36(5):353-73. PubMed ID: 10384859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives.
    Lau AH; Lam NP; Piscitelli SC; Wilkes L; Danziger LH
    Clin Pharmacokinet; 1992 Nov; 23(5):328-64. PubMed ID: 1478003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metronidazole].
    Martinez V; Caumes E
    Ann Dermatol Venereol; 2001 Sep; 128(8-9):903-9. PubMed ID: 11590342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secnidazole. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic use in the management of protozoal infections and bacterial vaginosis.
    Gillis JC; Wiseman LR
    Drugs; 1996 Apr; 51(4):621-38. PubMed ID: 8706597
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Mtshali A; Ngcapu S; Govender K; Sturm AW; Moodley P; Joubert BC
    Microbiol Spectr; 2022 Aug; 10(4):e0091222. PubMed ID: 35863010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tinidazole: a review of its antiprotozoal activity and therapeutic efficacy.
    Sawyer PR; Brogden RN; Pinder RM; Speight TM; Avery GS
    Drugs; 1976; 11(6):423-40. PubMed ID: 954609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro susceptibility of Trichomonas vaginalis to metronidazole, ornidazole and proton pump inhibitors pantoprazole and esomeprazole].
    Aksoy Gökmen A; Girginkardeşler N; Kilimcioğlu AA; Şirin MC; Özbilgin A
    Mikrobiyol Bul; 2016 Jan; 50(1):133-9. PubMed ID: 27058337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity and pharmacokinetics of nitroimidazoles. A review.
    Bergan T
    Scand J Infect Dis Suppl; 1985; 46():64-71. PubMed ID: 3865352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metronidazole. A therapeutic review and update.
    Freeman CD; Klutman NE; Lamp KC
    Drugs; 1997 Nov; 54(5):679-708. PubMed ID: 9360057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of omeprazole on the pharmacokinetics of metronidazole and hydroxymetronidazole in human plasma, saliva and gastric juice.
    Jessa MJ; Goddard AF; Barrett DA; Shaw PN; Spiller RC
    Br J Clin Pharmacol; 1997 Sep; 44(3):245-53. PubMed ID: 9296318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical pharmacokinetics of levofloxacin.
    Fish DN; Chow AT
    Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of nitroimidazoles. Spectrum of adverse reactions.
    Andersson KE
    Scand J Infect Dis Suppl; 1981; 26():60-7. PubMed ID: 6941457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A metronidazole-resistant strain of Trichomonas vaginalis and its sensitivity to Go 10213.
    Ray DK; Tendulkar JS; Shrivastava VB; Datta AK; Nagarajan K
    J Antimicrob Chemother; 1984 Oct; 14(4):423-6. PubMed ID: 6334072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PHARMACOKINETICS OF A SINGLE DOSE OF METRONIDAZOLE AFTER RECTAL ADMINISTRATION IN CAPTIVE ASIAN ELEPHANTS (ELEPHAS MAXIMUS).
    Sander SJ; Siegal-Willott JL; Ziegler J; Lee E; Tell L; Murray S
    J Zoo Wildl Med; 2016 Mar; 47(1):1-5. PubMed ID: 27010257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of the antitrichomonal activity of 5-nitroimidazole derivatives by hydrogen peroxide.
    Mattana A; Juliano C; Picci V; Franconi F; Cappuccinelli P
    New Microbiol; 1993 Oct; 16(4):359-65. PubMed ID: 8264426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diosmin pretreatment affects bioavailability of metronidazole.
    Rajnarayana K; Reddy MS; Krishna DR
    Eur J Clin Pharmacol; 2003 Apr; 58(12):803-7. PubMed ID: 12698306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of tinidazole and metronidazole in women after single large oral doses.
    Wood BA; Monro AM
    Br J Vener Dis; 1975 Feb; 51(1):51-3. PubMed ID: 1092424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of 5-nitroimidazole-resistant trichomonas vaginalis in Oviedo, Spain.
    Pérez S; Fernández-Verdugo A; Pérez F; Vázquez F
    Sex Transm Dis; 2001 Feb; 28(2):115-6. PubMed ID: 11234785
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of metronidazole in horses after intravenous, rectal and oral administration.
    Steinman A; Gips M; Lavy E; Sinay I; Soback S
    J Vet Pharmacol Ther; 2000 Dec; 23(6):353-7. PubMed ID: 11168912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of Gardnerella vaginalis to metronidazole, its bioactive metabolites, and tinidazole.
    Bannatyne RM; Jackowski J; Cheung R; Biers K
    Am J Clin Pathol; 1987 May; 87(5):640-1. PubMed ID: 3495168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.